(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 49.82% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Fortress Biotech's revenue in 2025 is $57,675,000.On average, 2 Wall Street analysts forecast FBIO's revenue for 2025 to be $2,999,161,452, with the lowest FBIO revenue forecast at $2,135,296,632, and the highest FBIO revenue forecast at $3,863,026,272. On average, 2 Wall Street analysts forecast FBIO's revenue for 2026 to be $4,184,945,128, with the lowest FBIO revenue forecast at $3,730,123,992, and the highest FBIO revenue forecast at $4,639,766,264.
In 2027, FBIO is forecast to generate $5,871,327,392 in revenue, with the lowest revenue forecast at $5,871,327,392 and the highest revenue forecast at $5,871,327,392.